Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495726 · ClinicalTrials.gov registry record · NA

Meditation for Pain

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
115
Enrollment target

NCT03495726 is a NA study that has completed, run by Emory University. The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495726, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target

Study Summary

The general scope of the study involves meditation and its effects on pain management, narcotic use, and emotional well-being. Half of the participants will receive access to a meditation app, which they will be asked to use for at least 10 minutes every day for 6 weeks, while the other participants will be in the waitlist group and will receive a subscription to the meditation app after the 6 week study period ends. All participants will be asked to complete a set of questionnaires

Interventions

  • BEHAVIORAL Headspace app

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2018-06-05
Est. Completion 2020-03-03
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03495726

The ClinicalTrials.gov registry entry for NCT03495726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Headspace app is the first listed.

NCT03495726 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03495726 about?

NCT03495726 is a clinical study titled "Meditation for Pain". The general scope of the study involves meditation and its effects on pain management, narcotic use, and emotional well-being. Half of the participants will receive access to a meditation app, which they will be asked to use for at least 10 minutes every day for 6 weeks, while the other participants...

What is the current status of trial NCT03495726?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2018-06-05. Estimated completion is 2020-03-03.

What interventions are being tested in trial NCT03495726?

The interventions under investigation include: Headspace app (BEHAVIORAL).

Who is sponsoring clinical trial NCT03495726?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.